RBC Capital analysts have assessed the impact of the CFTC’s approval of bitcoin perpetual futures, stating that the competitive risk to CME Group and Cboe Global Markets is manageable. Analyst Ashish Sabadra highlighted fundamental differences between perpetual futures and traditional exchange-listed contracts, along with limited institutional demand for these products.
The commentary from RBC comes in response to a notable decline in the stock prices of CME and Cboe following the Commodity Futures Trading Commission’s approval on May 29 of perpetual futures contracts for the prediction market platform Kalshi. CME’s stock fell over 5% on Monday and an additional 2.8% on Tuesday, while Cboe experienced a drop of more than 9% on Monday and an 8.4% decline the following day.
Investors expressed concerns that the approval could lead to the introduction of perpetual futures in other asset classes, such as equity derivatives, which could threaten the core offerings of traditional exchanges. RBC analysts noted that fears surrounding the migration of these products into S&P 500 and other structured products, where CME and Cboe have significant market positions, contributed to the stock declines.
Despite these concerns, RBC believes that the structural differences between perpetual futures and exchange-listed contracts, along with expected leverage limits set by clearing houses, will mitigate any competitive impact. The firm maintained its Sector Perform ratings for both CME and Cboe, indicating that while there may be limited short-term upside, the CFTC’s decision is not seen as a significant threat to their business models.
You can access our other news about Crypto and global market developments here.
